Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2010-01-31
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ADAPT-Altering Diet for African American Populations to Treat Hypertension
NCT00621569
Mindfulness Attitude to Deliver Dietary Approach to Stop Hypertension
NCT02830529
Dietary Approaches to Stop Hypertension (DASH)
NCT00000544
Effect of DASH on HF Outcomes Heart Failure Status in Older Adults (DASH HF)
NCT06296862
Diet Intervention for Hypertension: Adaptation and Dissemination to Native Communities
NCT02796313
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DASH materials
Participant randomized to a 12-week, group-based lifestyle intervention using modified DASH materials and intervention delivery approaches to help them adopt the DASH diet. Intervention content will be designed to provide participants with the knowledge and skills to adopt the DASH eating pattern, specifically to increase fruit, vegetable, and low-fat dairy intake, and to decrease saturated fats and sodium.
DASH diet
The intervention will consist of a 12-week pilot trial in which participants will be given intervention materials tailored to their community, focusing on DASH. Intervention content will be designed to provide participants with the knowledge and skills to adopt the DASH eating pattern, specifically to increase fruit, vegetable, and low-fat dairy intake, and to decrease saturated fats and sodium. They will follow this diet for 12 weeks.
Delayed intervention
The intervention participants will receive an NHLBI brochure entitled "Your Guide to Lowering Blood Pressure." They will then receive the modified DASH materials and the intervention at the end of the study, following the intervention group's completion of the study.
DASH diet
The intervention will consist of a 12-week pilot trial in which participants will be given intervention materials tailored to their community, focusing on DASH. Intervention content will be designed to provide participants with the knowledge and skills to adopt the DASH eating pattern, specifically to increase fruit, vegetable, and low-fat dairy intake, and to decrease saturated fats and sodium. They will follow this diet for 12 weeks.
Delayed Intervention
The participants will receive a guide written by NHLBI entitled, "Your Guide to Lowering Blood Pressure."
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DASH diet
The intervention will consist of a 12-week pilot trial in which participants will be given intervention materials tailored to their community, focusing on DASH. Intervention content will be designed to provide participants with the knowledge and skills to adopt the DASH eating pattern, specifically to increase fruit, vegetable, and low-fat dairy intake, and to decrease saturated fats and sodium. They will follow this diet for 12 weeks.
Delayed Intervention
The participants will receive a guide written by NHLBI entitled, "Your Guide to Lowering Blood Pressure."
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 21 years or older
* Residing in zip code 27105 or 27101
* Formal education less than 4-year college degree
* Blood pressure between 120/80 mmHg and 150/95 mmHg, inclusive (patients on BP lowering drugs eligible if BP is in above range)
* Willing to provide informed consent
* Able to participate in English
Exclusion Criteria
* Clinical history of diabetes, or newly diagnosed diabetes at screening
* Clinical history of renal insufficiency (Stage 3 or higher chronic kidney disease)
* BMI less than or equal to 18.5 kg/m2 or greater than or equal to 45.0 kg/m2
* Pregnancy
* Non-English speaker
21 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gramercy Research Group
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alain G Bertoni, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Melicia C Whitt-Glover, PhD
Role: PRINCIPAL_INVESTIGATOR
Gramercy Research Group
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.